These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2972456

  • 21. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW, Zech K, Fischer R.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [Abstract] [Full Text] [Related]

  • 22. [A comparative study of Unixan administered once daily and Theo-Dur administered twice daily].
    Dahl R, Pedersen B.
    Ugeskr Laeger; 1986 Sep 29; 148(40):2548-51. PubMed ID: 3535197
    [No Abstract] [Full Text] [Related]

  • 23. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ.
    Med Klin Prax; 1982 Aug 27; 77(18):48-53, 67. PubMed ID: 6752679
    [Abstract] [Full Text] [Related]

  • 24. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
    Harder S, Staib AH, Stauder J.
    Prax Klin Pneumol; 1985 Jun 27; 39(6):193-6. PubMed ID: 4022931
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I.
    Fortschr Med; 1982 Mar 25; 100(12):547-50. PubMed ID: 7042500
    [No Abstract] [Full Text] [Related]

  • 29. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
    Eichhorn J, Perré R.
    Med Welt; 1982 Dec 17; 33(50):1834-7. PubMed ID: 6762480
    [No Abstract] [Full Text] [Related]

  • 30. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H, Wilkens JH, Oellerich M, Sybrecht GW.
    Eur J Respir Dis; 1985 Mar 17; 66(3):196-204. PubMed ID: 3884358
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Individual theophylline doses following ambulatory determination of theophylline clearance].
    Harder S, Staib AH, Stauder J.
    Prax Klin Pneumol; 1986 Aug 17; 40(8):334-8. PubMed ID: 3748986
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Steady-state pharmacokinetics of two sustained-release theophylline products during once-daily and twice-daily dosing.
    Armstrong EP, Nako N, Plezia PM, Kramer TH, Jones WN.
    Clin Pharm; 1987 Oct 17; 6(10):800-4. PubMed ID: 3505842
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Therapy of nocturnal bronchial asthma: comparison of various doses of retard theophylline].
    Dorow P, Steinijans VW.
    Prax Klin Pneumol; 1987 Oct 17; 41(10):442-4. PubMed ID: 3325964
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Unequal twice-daily, sustained-release theophylline dosing in chronic obstructive pulmonary disease.
    Bruguerolle B, Philip-Joet F, Parrel M, Arnaud A.
    Chronobiol Int; 1987 Oct 17; 4(3):381-5. PubMed ID: 3315267
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.